Dysregulated serum response factor triggers formation of hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

http://www.wikidata.org/entity/Q28390147

about

The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.Decreased expression of long non-coding RNA LOC728290 in human hepatocellular carcinoma.

P2860

Q42803531-0486FF45-FF83-4013-966A-12C386AA2721 Q47143020-4AEF1DC5-804F-4C2F-BD90-932C65CD4212

P2860

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

http://www.wikidata.org/entity/Q28390147

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@ast

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@en

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@nl

type

label

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@ast

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@en

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@nl

prefLabel

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@ast

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@en

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@nl

P1433

Q28390147-95C1A95E-74AD-4FCE-A63F-689C7C068A3A

P1476

Q28390147-F68EE847-308E-488C-9F5A-58EE76772AA4

P2093

Q28390147-07F1766D-94C9-4F42-A58D-1094A700EA28

Q28390147-3B95416D-51E8-4544-A9DD-BCF59473A2BC

Q28390147-3CFBEDD5-C47A-4E77-9772-D9FFDB1F7212

Q28390147-4BE9DF0B-8A11-4A18-AF8B-F9284C90EDE0

Q28390147-5B350C72-B963-4CB5-8522-656E1C4FB32D

Q28390147-69A221A8-2B55-4DFB-959D-AEC65BF33D0D

Q28390147-7EBC33C4-F110-4171-997C-2AA7AD223FF3

Q28390147-827D5D1F-2E1F-47C8-AC05-E51D90D2FF2C

Q28390147-94AC2CDB-A187-4CBC-B9E1-261F6F34405B

Q28390147-AAA99E50-BC20-4B08-B003-1B1DD2E44C9D

P2860

Q28390147-02E59287-AB38-489B-89F8-DD108382E17E

Q28390147-07AE37F3-FAE4-4289-9BD5-14DE6183FAC0

Q28390147-1DF671D3-52EA-4FA1-B7EE-9513958BF778

Q28390147-34451886-E796-4E37-9438-47A985133CA8

Q28390147-3CA26171-B46C-4A1B-9A34-E773BE084F5B

Q28390147-41132DBA-5CF1-49B0-9994-1AF22F2432CD

Q28390147-48656D2B-F730-4993-B837-0248D1F30389

Q28390147-532FFD7C-BB06-4B10-8482-20BD79AFE764

Q28390147-5CE1B35B-C56F-4787-A368-6769B5011FFC

Q28390147-870A9708-B8E0-49EE-AEBE-6DA60075211C

P304

Q28390147-215407A4-0A13-4645-94E9-26ED5F20C3FA

P31

Q28390147-013D1A85-B51D-47CE-8962-350E2CD362CE

P356

Q28390147-16F9E302-5B9D-4B02-B7B9-BD9BBEDCC3D8

P407

Q28390147-81FC5291-38BD-44CF-9F64-26C55265D965

P433

Q28390147-82D2BE55-0953-40D4-8740-B4FAA70A8A54

P478

Q28390147-0B44FDF0-8E8F-4B17-AB87-F29A6462642C

P50

Q28390147-8E0CF7C7-4F42-4D6F-AA0E-F37885D7D967

Q28390147-93135E5A-AEBB-43F6-8B2A-57B51CFCD220

P577

Q28390147-0B996668-128A-4C99-B5AD-AC1A167BE399

P5875

Q28390147-1D41EC14-EBAC-4B8B-8AEC-113188720C5D

P698

Q28390147-22267DF7-C6F4-4442-80A9-A40F2347B4E0

P932

Q28390147-A456B448-DF82-4C94-85C9-F7F750C91A8F

P356

P1433

P1476

Dysregulated serum response factor triggers formation of hepatocellular carcinoma

@en

P2093

Abhishek Thavamani

http://www.w3.org/2001/XMLSchema#string

Albert Braeuning

http://www.w3.org/2001/XMLSchema#string

Alfred Nordheim

http://www.w3.org/2001/XMLSchema#string

Andreas Zell

http://www.w3.org/2001/XMLSchema#string

Christoph Plass

http://www.w3.org/2001/XMLSchema#string

Günther Schütz

http://www.w3.org/2001/XMLSchema#string

Michael Bonin

http://www.w3.org/2001/XMLSchema#string

Michael Römer

http://www.w3.org/2001/XMLSchema#string

Michael Schwarz

http://www.w3.org/2001/XMLSchema#string

Milen Kirilov

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

DLC-1: a Rho GTPase-activating protein and tumour suppressor

The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib

DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma

DLC1: a significant GAP in the cancer genome

RHO-GTPases and cancer

Degeneration of the mouse retina upon dysregulated activity of serum response factor.

TAp63 induces senescence and suppresses tumorigenesis in vivo.

Linking actin dynamics and gene transcription to drive cellular motile functions.

P304

979-989

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.27539

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

Alfred Nordheim

P577

2015-01-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266206113

http://www.w3.org/2001/XMLSchema#string

P698

25266280

http://www.w3.org/2001/XMLSchema#string

P932

4365683

http://www.w3.org/2001/XMLSchema#string